|
Welcome
|
|
02 September 2010
|
|
|
| home | my details | ISRCTN Register | mRCT | links | information | press |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
| [ Print-friendly version ] |
| Reflex |
| ISRCTN | ISRCTN50247539 |
| ClinicalTrials.gov identifier | |
| Public title | Reflex |
| Scientific title | |
| Acronym | N/A |
| Serial number at source | ABR 27146 |
| Study hypothesis |
Current information as of 10/12/09:
The preconditions of poor insight in schizophrenia, self-reflection, idiosyncratic self-certainty and stigma sensitivity, can be improved by a treatment aiming to stimulate perspective taking and to decrease of internalized stigma. Initial information at time of registration: Can poor insight with schizophrenia be improved with a treatment aimed at self-reflection and the decrease of internalized stigmata? Please note that as f 10/12/09 this record has been extensively updated. All updates can be found under the relevant field with the above update date. In addition, please note that the target number of participants has been changed from 80 to 145. The anticipated start and end dates for this trial have been updated from 01/09/2009 and 01/09/2011 to 01/05/2010 and 01/10/2011. |
| Ethics approval |
Added 10/12/09:
Approved by the Medical Ethical Testing Committee (METc) UMCG on 13th of October 2009 |
| Study design | Multi-centre randomised controlled trial |
| Countries of recruitment | Netherlands |
| Disease/condition/study domain | Psychic disorders; schizophrenia and other psychotic disorders |
| Participants - inclusion criteria |
1. Both males and females, age: 18 years or older
2. A diagnosis of schizophrenia according to Diagnostic And Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria 3. Impaired insight (based on structured assessment) (PI< 9) 4. Internalized stigma (ISMIS items 6+13+17+18 <6 ) 5. Able to give informed consent Initial information at time of registration: 1. Both males and females, age between: 18-65 2. A diagnosis of schizophrenia according to Diagnostic And Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria 3. Impaired insight (based on structured assessment) 4. Willing to give written informed consent |
| Participants - exclusion criteria |
Current information as of 10/12/09:
1. Florid psychosis 2. Co-morbid neurological disorder Initial information at time of registration: 1. Florid psychosis 2. Patients falling under the BOPZ law, or who are unable to give informed consent according to the ‘Wet op Geneeskundige Behandelovereenkomsten’ 3. Co-morbid neurological disorder 4. IQ below 75 |
| Anticipated start date | 01/05/2010 |
| Anticipated end date | 01/10/2011 |
| Status of trial | Ongoing |
| Patient information material | Not available in web format, please use the contact details below to request a patient information sheet |
| Target number of participants | Added 10/12/09: 145 |
| Interventions |
Current information as of 10/12/09:
Patients will have 12 one-hour group therapy sessions with a psychologist. The training consists of three modules, each module consists of four group sessions. During these sessions patients are stimulated to reflect upon their own thoughts, behavior and feelings and integrate changes that have occurred during their illness in the self-image. They are constantly encouraged to distinguishing factual information from opinions and to take the perspective of others. The active control condition consists of group wise drill and practice cognitive remediation training.The total duration of the intervention will be 12 hours. Initial information at time of registration: Patients will have 16 group therapy sessions with a psychologist. In these sessions, stigmatising beliefs are disputed and self-reflection is stimulated. On a daily basis SMS-messages will be sent to stimulate self-reflection. After a prompt patients are required to fill out a short form with short questions about their cognitions and emotions. Weekly group sessions will be based on the patients' responses. Control condition: care as usual and additional befriending sessions with a therapist. The total duration of interventions will be 16 hours. Follow-up assessments will take 3 x 90 minutes. |
| Primary outcome measure(s) |
Current information as of 10/12/09:
Self-reflection, idiosyncratic self-certainty and stigma sensitivity: 1. Beck Cognitive Insight Scale (BCIS) 2. Selfreflection and Insight Scale (ZRIS) 3. Internalised Stigma: Internalized Stigma of Mental Illness Scale (ISMIS) Initial information at time of registration Insight, assessed by the following: 1. Beck Cognitive Insight Scale (BCIS) 2. Schedule for the Assessment of Insight - Expanded Version (SAI-E) |
| Secondary outcome measure(s) |
Current information as of 10/12/09:
Depression, symptoms, self-esteem and quality of life: 1. Insight (SAI-E) 2. Depression: Beck Depression Inventory (BDI-II) 3. Symptoms: Positive and Negative Syndrome Scale (PANSS) 4. Self-esteem 5. Quality of life: Manchester Short Assessment of Quality of Life (MANSA) Initial information at time of registration: Social functioning, depression, internalised stigma, quality of life and symptoms will be assessed by the following: 1. Community Functioning: Social Functioning Scale 2. Depression: Beck Depression Inventory (BDI-II) 3. Symptoms: Positive and Negative Syndrome Scale (PANSS) 4. Internalised Stigma: Internalized Stigma of Mental Illness Scale (ISMIS) 5. Self-esteem: Self-Esteem Rating Scale (SERS) SF-20 (Dutch version) 6. Quality of life: Manchester Short Assessment of Quality of Life (MANSA) |
| Sources of funding | European Science Foundation/ The Netherlands Organization for Scientific Research (NWO) (Netherlands) |
| Trial website | |
| Publications | |
| Contact name | Prof Andre Aleman |
| Address |
Department of Neurosciences
NeuroImaging Centre Groningen Cognitive Neuropsychiatry Ant. Deusinglaan 2 |
| City/town | Groningen |
| Zip/Postcode | 9713 AW |
| Country | Netherlands |
| a.aleman@med.umcg.nl | |
| Sponsor | University Medical Center Groningen (UMCG) (Netherlands) |
| Address | Hanzeplein 1 |
| City/town | Groningen |
| Zip/Postcode | 9700 RB |
| Country | Netherlands |
| a.aleman@med.umcg.nl | |
| Sponsor website: | http://www.umcg.nl |
| Date applied | 04/05/2009 |
| Last edited | 10/12/2009 |
| Date ISRCTN assigned | 30/06/2009 |
|
|
|
|
|
| © 2010 ISRCTN unless otherwise stated. | |
|
|
|
|